Ocunexus Therapeutics Funding: $65M Raised, Series A (2021)

Ocunexus Therapeutics funding overview

Ocunexus Therapeutics is based in San Diego. Ocunexus Therapeutics has raised $65M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in January 2021. The round record for Ocunexus Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Domain Associates, Kleiner Perkins, Versant Ventures, Biopacificventures, GBS Venture Partners, Rusnanomedinvest. 6 distinct backers are named across the disclosed rounds.

Ocunexus Therapeutics at a glance

Total raised: $65M
Latest round: Series A
Latest round date: January 2021
Headquarters: San Diego
Notable investors: Domain Associates, Kleiner Perkins, Versant Ventures, Biopacificventures, GBS Venture Partners, Rusnanomedinvest

Frequently asked about Ocunexus Therapeutics funding

How much has Ocunexus Therapeutics raised?: Ocunexus Therapeutics has raised $65M in total disclosed funding across the rounds on record.
Who has invested in Ocunexus Therapeutics?: Domain Associates, Kleiner Perkins, Versant Ventures, Biopacificventures, GBS Venture Partners, Rusnanomedinvest are named among the investors backing Ocunexus Therapeutics.
What was the latest Ocunexus Therapeutics funding round?: The most recent disclosed round is a Series A, announced in January 2021.
Where is Ocunexus Therapeutics based?: Ocunexus Therapeutics is based in San Diego.
When did Ocunexus Therapeutics last raise?: The last disclosed Ocunexus Therapeutics round closed in January 2021 at Series A.

Ocunexus Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in San Diego below to benchmark round size and investor mix.

Ocunexus Therapeutics Funding: $65M Raised, Series A (2021)

Ocunexus Therapeutics funding overview

Ocunexus Therapeutics at a glance

Frequently asked about Ocunexus Therapeutics funding

Companies related to Ocunexus Therapeutics (27)

Browse related funding lists (8)